C646-loaded mesenchymal stromal cell extracellular vesicles alleviate lactate-driven immunoparalysis in sepsis-associated ARDS through the p300-H3K18la-PSMD14 axis
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.117346 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Yuanyuan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Sepsis, Respiratory Distress Syndrome, Mesenchymal Stem Cells. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China, Jinan Science and Technology Bureau.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis-associated acute respiratory distress syndrome (S-ARDS) is often followed by immunoparalysis, leaving patients vulnerable to secondary infection and adverse outcomes. Lactate is widely used as a severity marker in sepsis, but its direct contribution to immune paralysis remains unclear. We examined lactate-driven immune dysfunction in mouse models, bone marrow-derived macrophages and human CD14+ monocyte-derived macrophages, and tested C646-loaded mesenchymal stromal cell-derived extracellular vesicles (EVs-C646) as an experimental intervention. Lactate elevation blunted cytokine responses after rechallenge, reduced macrophage phagocytosis, shifted macrophages toward an M2-like phenotype, expanded regulatory T cells and decreased interferon-γ (IFN-γ) responses in CD8+ T cells. Mechanistically, lactate activated a p300-histone H3 lysine 18 lactylation (H3K18la) program and upregulated proteasome 26S subunit, non-ATPase 14 (PSMD14). Integrated RNA sequencing, H3K18la chromatin immunoprecipitation sequencing, public sepsis transcriptomic analysis and perturbation experiments identified PSMD14 as a lactylation-linked effector that strengthened AKT/mTOR signalling and promoted macrophage dysfunction. EVs-C646 decreased H3K18la and PSMD14 expression, restored macrophage inflammatory responsiveness, improved bacterial clearance, reduced lung injury and increased survival in experimental S-ARDS-related immunoparalysis models. These findings define a lactate-p300-H3K18la-PSMD14-AKT/mTOR pathway in immunoparalysis and support further preclinical evaluation of lactylation-targeted extracellular vesicle therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
- Department of Pulmonary and Critical Care Medicine, Shandong Provincial Third Hospital, Shandong University, Jinan 250031, China.
- Department of Pulmonary and Critical Care Medicine, Shandong Provincial Third Hospital, Shandong University, Jinan 250031, China. Electronic address: 394873967@qq.com.
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Jinan Science and Technology Bureau
Zitieren
APA
Zhang, Y., Guo, J., Zhang, J., Zheng, Y., Wang, H., & Zhang, S. (2026). C646-loaded mesenchymal stromal cell extracellular vesicles alleviate lactate-driven immunoparalysis in sepsis-associated ARDS through the p300-H3K18la-PSMD14 axis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117346
Vancouver
Zhang Y, Guo J, Zhang J, Zheng Y, Wang H, Zhang S. C646-loaded mesenchymal stromal cell extracellular vesicles alleviate lactate-driven immunoparalysis in sepsis-associated ARDS through the p300-H3K18la-PSMD14 axis. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117346
BibTeX
@article{Zhang2026,
author = {Zhang, Yuanyuan and Guo, Jiaxu and Zhang, Jiamin and Zheng, Yiqun and Wang, Hao and Zhang, Shi},
title = {C646-loaded mesenchymal stromal cell extracellular vesicles alleviate lactate-driven immunoparalysis in sepsis-associated ARDS through the p300-H3K18la-PSMD14 axis},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.117346}
}
EUVIMED